Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H43NO8 |
Molecular Weight | 509.6322 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12[C@H](OC(=O)CCN(C)C)[C@H](OC(C)=O)[C@@]3(C)O[C@](C)(CC(=O)[C@]3(O)[C@@]1(C)[C@@H](O)CCC2(C)C)C=C
InChI
InChIKey=RSOZZQTUMVBTMR-XGUNBQNXSA-N
InChI=1S/C27H43NO8/c1-10-24(5)15-18(31)27(33)25(6)17(30)11-13-23(3,4)21(25)20(35-19(32)12-14-28(8)9)22(34-16(2)29)26(27,7)36-24/h10,17,20-22,30,33H,1,11-15H2,2-9H3/t17-,20-,21-,22-,24-,25-,26+,27-/m0/s1
DescriptionSources: http://adisinsight.springer.com/drugs/800001302Curator's Comment: Description was created based on several sources, including
http://www.genome.jp/dbget-bin/www_bget?D01697 and https://www.ncbi.nlm.nih.gov/pubmed/12499623
Sources: http://adisinsight.springer.com/drugs/800001302
Curator's Comment: Description was created based on several sources, including
http://www.genome.jp/dbget-bin/www_bget?D01697 and https://www.ncbi.nlm.nih.gov/pubmed/12499623
Colforsin daropate (a derivative of Colforsin) is cardiotonic, adenylate cyclase activator. It is reported as an ingredient of Adehl in Japan. Colforsin daropate hydrochloride is used for the treatment of acute heart failure. Colforsin daropate is capable of directly stimulating adenylate cyclase, which in turn causes vasorelaxation via elevated intracellular concentrations of cyclic adenosine monophosphate, making it a useful therapeutic tool in treating cerebral vasospasm.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10217303
Curator's Comment: COLFORSIN DAROPATE has been reported to penetrate the blood- brain barrier after peripheral administration and can thereby be used to activate adenylyl cyclase in the CNS
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2097167 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10511949 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Adehl Approved UseAcute heart failure |
PubMed
Title | Date | PubMed |
---|---|---|
Effect of mild hypothermia on inodilator-induced vasodilation of pial arterioles in cats. | 2002 Oct |
|
Expression of aquaporin 8 and its up-regulation by cyclic adenosine monophosphate in human WISH cells. | 2003 Apr |
|
Both milrinone and colforsin daropate attenuate the sustained pial arteriolar constriction seen after unclamping of an abdominal aortic cross-clamp in rabbits. | 2005 Jul |
|
Beta-adrenoceptor-mediated vasodilation of retinal blood vessels is reduced in streptozotocin-induced diabetic rats. | 2008 Aug-Sep |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12826837
0.75 ug kg-1 x min-1 colforsin daropate intravenously
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14512698
COLFORSIN DAROPATE (10(-7)-10(-5) mol/l) inhibited [(3)H]thymidine incorporation into cultured rat MCs in a concentration-dependent manner.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1196KQZ976
Created by
admin on Sat Dec 16 04:51:36 UTC 2023 , Edited by admin on Sat Dec 16 04:51:36 UTC 2023
|
PRIMARY | |||
|
729
Created by
admin on Sat Dec 16 04:51:36 UTC 2023 , Edited by admin on Sat Dec 16 04:51:36 UTC 2023
|
PRIMARY | |||
|
DTXSID20150415
Created by
admin on Sat Dec 16 04:51:36 UTC 2023 , Edited by admin on Sat Dec 16 04:51:36 UTC 2023
|
PRIMARY | |||
|
113462-26-3
Created by
admin on Sat Dec 16 04:51:36 UTC 2023 , Edited by admin on Sat Dec 16 04:51:36 UTC 2023
|
PRIMARY | |||
|
444029
Created by
admin on Sat Dec 16 04:51:36 UTC 2023 , Edited by admin on Sat Dec 16 04:51:36 UTC 2023
|
PRIMARY |
SUBSTANCE RECORD